Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676 · see citing works

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · see citing works

Differential Regulation of Dynein and Kinesin Motor Proteins by Tau

Dixit, R., Ross, J. L., Goldman, Y. E., & Holzbaur, E. L. F. (2008) · Science · doi:10.1126/science.1152993 · Cited by 1,012 · see citing works

Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

Drechsel, D. N., Hyman, A. A., Cobb, M. H., & Kirschner, M. W. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.10.1141 · Cited by 971 · see citing works

Tauopathy in <i>Drosophila</i> : Neurodegeneration Without Neurofibrillary Tangles

Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939 · see citing works

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · see citing works

Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly

Cleveland, D. W., Hwo, S. Y., & Kirschner, M. W. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90214-5 · Cited by 881 · see citing works

Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau)

Wood, J. G., Mirra, S. S., Pollock, N. J., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4040 · Cited by 749 · see citing works

Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738 · see citing works

DEFECTIVE BRAIN MICROTUBULE ASSEMBLY IN ALZHEIMER'S DISEASE

Iqbal, K., Zaidi, T., Wen, G. Y., Grundke, I., MERZ, P. A., Shaikh, S., Wisniewski, H., Alafuzoff, I. I., & Winblad, B. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92134-3 · Cited by 727 · see citing works

Domains of tau Protein and Interactions with Microtubules

Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E.-M., & Mandelkow, E. (1994) · Biochemistry · doi:10.1021/bi00198a017 · Cited by 655 · see citing works

Mechanisms of tau-induced neurodegeneration

Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628 · see citing works

Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform

Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M. K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81127-7 · Cited by 564 · see citing works

Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly

Hasegawa, M., Smith, M. J., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01217-4 · Cited by 482 · see citing works

Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells

Lovestone, S., Reynolds, C. H., Latimer, D. A., Davis, D. R., Anderton, B. H., Gallo, J., Hanger, D. P., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 470 · see citing works

Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau

Alonso, A. D. C., Grundke-Iqbal, I., Barra, H. S., & Iqbal, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.298 · Cited by 437 · see citing works

Synaptic slaughter in Alzheimer's disease

Coleman, P. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.001 · Cited by 351 · see citing works

Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles

Trinczek, B., Ebneth, A., Mandelkow, E.-M., & Mandelkow, E. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.14.2355 · Cited by 344 · see citing works

Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.

Trinczek, B., Biernat, J., Baumann, K., Mandelkow, E. M., & Mandelkow, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.12.1887 · Cited by 340 · see citing works

Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations

Alonso, A. D. C., Mederlyova, A., Novák, M., Grundke, I., & Iqbal, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405131200 · Cited by 330 · see citing works

Microtubule Reduction in Alzheimer's Disease and Aging Is Independent of τ Filament Formation

Cash, A., Aliev, G. M., Siedlak, S. L., Nunomura, A., Fujioka, H., Zhu, X., Raina, A. K., Vinters, H. V., Tabaton, M., Johnson, T., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64296-4 · Cited by 309 · see citing works

Tau domains, phosphorylation, and interactions with microtubules

Mandelkow, E.-M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B., & Mandelkow, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00025-a · Cited by 308 · see citing works

The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy

Mocanu, M.-M., Nissen, A., Eckermann, K., Khlistunova, I., Biernat, J., Drexler, D., Petrova, O., Schönig, K., Bujard, H., Mandelkow, E., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2824-07.2008 · Cited by 297 · see citing works

Reduction of Soluble Aβ and Tau, but Not Soluble Aβ Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles

Oddo, S., Vasilevko, V., Caccamo, A., Kitazawa, M., Cribbs, D. H., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608485200 · Cited by 282 · see citing works

Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B

Wang, J.-Z., Gong, C.-X., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4854 · Cited by 269 · see citing works

GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila

Mudher, A., Shepherd, D., Newman, T. A., Mildren, P., Jukes, J. P., Squire, A., Mears, A., Berg, S., MacKay, D., Asuni, A. A., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001483 · Cited by 265 · see citing works

MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons

Mandelkow, E.-M., Thies, E., Trinczek, B., Biernat, J., & Mandelkow, E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200401085 · Cited by 236 · see citing works

Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation

Dayanandan, R., van Slegtenhorst, M., Mack, T. G. A., Ko, L., Yen, S. H., Leroy, K., Brion, J., Anderton, B. H., Hutton, M. L., & Lovestone, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00222-7 · Cited by 210 · see citing works

Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity

Alonso, A. D. C., Li, B., Grundke-Iqbal, I., & Iqbal, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603214103 · Cited by 206 · see citing works

TauGene Mutation G389R Causes a Tauopathy with Abundant Pick Body-like Inclusions and Axonal Deposits

Murrell, J. R., Spillantini, M. G., Zolo, P., Guazzelli, M., Smith, M. J., Hasegawa, M., Redi, F., Crowther, R. A., Pietrini, P., Ghetti, B. F., et al. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199912000-00002 · Cited by 205 · see citing works

Phosphorylation of tau by glycogen synthase kinase-3β in intact mammalian cells: The effects on the organization and stability of microtubules

Lovestone, S., Hartley, C. L., Pearce, J., & Anderton, B. H. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00126-1 · Cited by 201 · see citing works

Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death

Feinstein, S. C., & Wilson, L. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.07.002 · Cited by 191 · see citing works

Tau Becomes a More Favorable Substrate for GSK-3 When It Is Prephosphorylated by PKA in Rat Brain

Liu, S. J., Zhang, J. Y., Li, H. L., Fang, Z., Wang, Q., Deng, H. M., Gong, C. X., Grundke, I., Iqbal, K., & Wang, J. Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406109200 · Cited by 186 · see citing works

Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.

Ishihara, T., Zhang, B., Higuchi, M., Yoshiyama, Y., Trojanowski, J., & Lee, V. (2001) · American Journal of Pathology · doi:10.1016/s0002-9440(10)63997-1 · Cited by 178 · see citing works

Dissociation of tau toxicity and phosphorylation: role of GSK-3β, MARK and Cdk5 in a Drosophila model

Chatterjee, S., Sang, T.-K., Lawless, G. M., & Jackson, G. R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn326 · Cited by 178 · see citing works

Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau

Li, B., Chohan, M. O., Grundke, I., & Iqbal, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0207-8 · Cited by 173 · see citing works

Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia

Suzuki, K., & Terry, R. D. (1967) · Acta Neuropathologica · doi:10.1007/bf00688828 · Cited by 169 · see citing works

The role of PAR-1 in regulating the polarised microtubule cytoskeleton in theDrosophilafollicular epithelium

Doerflinger, H., Benton, R., Shulman, J. M., & Johnston, D. S. (2003) · Development · doi:10.1242/dev.00616 · Cited by 160 · see citing works

Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations

Lovestone, S., Davis, D. R., Webster, M.-T., Kaech, S., Brion, J., Matus, A. I., & Anderton, B. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00183-8 · Cited by 157 · see citing works

Restoration of biological activity of Alzheimer abnormally phosphorylated τ by dephosphorylation with protein phosphatase-2A, −2B and −1

Wang, J., Grundke, I., & Iqbal, K. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00316-k · Cited by 154 · see citing works

Surface-decoration of Microtubules by Human Tau

Santarella, R. A., Skiniotis, G., Goldie, K. N., Tittmann, P., Gross, H., Mandelkow, E., Mandelkow, E., & Hoenger, A. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.04.008 · Cited by 141 · see citing works

T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls

Hellings, N., Bar�e, M., Verhoeven, C., D'hooghe, M. B., Medaer, R., Bernard, C. C. A., Raus, J., & Stinissen, P. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010201)63:3 · Cited by 138 · see citing works

Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions

Chee, F. C., Mudher, A. K., Cuttle, M. F., Newman, T. A., Mackay, D., Lovestone, S., & Shepherd, D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.029 · Cited by 119 · see citing works

The ‘jaws’ model of tau-microtubule interaction examined in CHO cells

Preuß, U., Biernat, J., Mandelkow�, E., & Mandelkow�, E. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.6.789 · Cited by 108 · see citing works

Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease

Praprotnik, D., Smith, M. A., Richey, P. L., Vinters, H. V., & Perry, G. L. (1996) · Acta Neuropathologica · doi:10.1007/s004010050420 · Cited by 98 · see citing works

Anesthesia-Induced Hyperphosphorylation Detaches 3-Repeat Tau from Microtubules without Affecting Their Stability<i>In Vivo</i>

Planel, E., Krishnamurthy, P., Miyasaka, T., Liu, L., Herman, M., Kumar, A., Bretteville, A., Figueroa, H. Y., Haung Yu, W., Whittington, R. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4101-08.2008 · Cited by 79 · see citing works

Cytosolic Abnormally Hyperphosphorylated Tau But Not Paired Helical Filaments Sequester Normal MAPs and Inhibit Microtubule Assembly

Iqbal, K., Alonso, A. D. C., & Grundke, I. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14402 · Cited by 77 · see citing works

Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro

Han, D., Qureshi, H. Y., Lu, Y., & Paudel, H. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901095200 · Cited by 40 · see citing works

A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies

Ubhi, K. K., Shaibah, H., Newman, T. A., Shepherd, D., & Mudher, A. K. (2007) · Invertebrate Neuroscience · doi:10.1007/s10158-007-0052-4 · Cited by 39 · see citing works

Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R

Br�ckner, G., Grosche, J., Schmidt, S., H�rtig, W., Margolis, R. U., Delpech, B., Seidenbecher, C. I., Czaniera, R., & Schachner, M. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001225)428:4

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194 · see citing works

The pathological process underlying Alzheimer’s disease in individuals under thirty

Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812 · see citing works

The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease

Braak, H., & Del Tredici, K. (2015) · Brain · doi:10.1093/brain/awv236 · Cited by 540 · see citing works

Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation

Huat, T. J., Camats‐Perna, J., Newcombe, E. A., Valmas, N., Kitazawa, M., & Medeiros, R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.018 · Cited by 483 · see citing works

Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction

Mietelska‐Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 407 · see citing works

What is the evidence that tau pathology spreads through prion-like propagation?

Mudher, A., Colin, M., Dujardin, S., Medina, M., Dewachter, I., Alavi Naini, S. M., Mandelkow, E.-M., Mandelkow, E., Buée, L., Goedert, M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0488-7 · Cited by 384 · see citing works

Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?

Braak, H., & Tredici, K. D. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0825-z · Cited by 359 · see citing works

Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage

Shafiei, S. S., Guerrero-Muñoz, M. J., & Castillo-Carranza, D. L. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00083 · Cited by 314 · see citing works

Where, when, and in what form does sporadic Alzheimerʼs disease begin?

Braak, H., & Tredici, K. D. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a3432 · Cited by 252 · see citing works

Protein phosphorylation in neurodegeneration: friend or foe?

Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252 · see citing works

Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease

Kitagishi, Y., Nakanishi, A., Ogura, Y., & Matsuda, S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt265 · Cited by 246 · see citing works

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu, E., Zhang, Y., & Wang, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 220 · see citing works

Are tau aggregates toxic or protective in tauopathies?

Cowan, C. M., & Mudher, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00114 · Cited by 215 · see citing works

Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes

Scheiblich, H., Eikens, F., Wischhof, L., Opitz, S., Jüngling, K., Cserép, C., Schmidt, S. V., Lambertz, J., Bellande, T., Pósfai, B., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.06.029 · Cited by 207 · see citing works

Tau-mediated disruption of the spliceosome triggers cryptic rna splicing and neurodegeneration in Alzheimer's Disease

Hsieh, Y.-C., Guo, C., Yalamanchili, H. K., Abreha, M., Al-Ouran, R., Li, Y., Dammer, E. B., Lah, J. J., Levey, A. I., Bennett, D. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.104 · Cited by 196 · see citing works

Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease

Guerrero-Muñoz, M. J., Gerson, J., & Castillo-Carranza, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00464 · Cited by 168 · see citing works

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

Braak, H., Zetterberg, H., Tredici, K. D., & Blennow, K. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1139-0 · Cited by 141 · see citing works

Cell-to-Cell Transmission of Tau and α-Synuclein

Uemura, N., Uemura, M. T., Luk, K. C., Lee, V. M. ‐., & Trojanowski, J. Q. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.03.012 · Cited by 141 · see citing works

Formation and Propagation of Tau Oligomeric Seeds

Gerson, J. E., & Kayed, R. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00093 · Cited by 137 · see citing works

Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer’s disease

Chen, S., Chen, S., Sun, Y., Xu, Z., Wang, Y., Yao, S., Yao, W., & Gao, X. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101133 · Cited by 119 · see citing works

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)

Mroczko, B., Groblewska, M., & Litman‐Zawadzka, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194661 · Cited by 106 · see citing works

Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates

Gyparaki, M. T., Arab, A., Sorokina, E. M., Santiago-Ruiz, A. N., Bohrer, C. H., Xiao, J., & Lakadamyali, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021461118 · Cited by 96 · see citing works

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow

Kim, A. Y., Jerdi, S. A., MacDonald, R., & Triggle, C. R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399121 · Cited by 93 · see citing works

Stimulation of TLR4 Attenuates Alzheimer’s Disease–Related Symptoms and Pathology in Tau-Transgenic Mice

Qin, Y., Liu, Y., Hao, W., Decker, Y., Tomic, I., Menger, M. D., Liu, C., & Fassbender, K. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600873 · Cited by 90 · see citing works

Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease

Pérez, M. J., Vergara-Pulgar, K., Jara, C., Cabezas-Opazo, F., & Quintanilla, R. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0385-x · Cited by 81 · see citing works

Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy

Pramanik, S., Sulistio, Y. A., & Heese, K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0214-7 · Cited by 77 · see citing works

The Ubiquitin System in Alzheimer’s Disease

Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 76 · see citing works

NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy

Quraishe, S., Cowan, C. M., & Mudher, A. K. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.32 · Cited by 76 · see citing works

Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology

Koss, D. J., Robinson, L., Drever, B. D., Plucińska, K., Stoppelkamp, S., Veselcic, P., Riedel, G., & Platt, B. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.002 · Cited by 76 · see citing works

P-tau217 correlates with neurodegeneration in Alzheimer’s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy

Zhang, D., Zhang, W., Chen, M., Gao, X., Yuan, H., Lin, X., Mao, X., Wang, C., Guo, X., Du, Y., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.02.017 · Cited by 74 · see citing works

Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species

Gerson, J. E., Castillo‐Carranza, D. L., & Kayed, R. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500143n · Cited by 73 · see citing works

Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy

Sealey, M. A., Vourkou, E., Cowan, C. M., Bossing, T., Quraishe, S., Grammenoudi, S., Skoulakis, E. M. C., & Mudher, A. K. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.003 · Cited by 73 · see citing works

Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity

Butzlaff, M., Hannan, S. B., Karsten, P., Lenz, S., Ng, J., Voßfeldt, H., Prüßing, K., Pflanz, R., Schulz, J. B., Rasse, T. M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv107 · Cited by 72 · see citing works

Modeling the complex pathology of Alzheimer's disease in Drosophila

Fernandez-Funez, P., de Mena, L., & Rincon-Limas, D. E. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.013 · Cited by 69 · see citing works

Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress

Goodman, L. D., Ralhan, I., Li, X., Lu, S., Moulton, M. J., Park, Y.-J., Zhao, P., Kanca, O., Taleghani, Z. S. G., Jacquemyn, J., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01740-1 · Cited by 67 · see citing works

Molecular Chaperones and Regulation of Tau Quality Control: Strategies for Drug Discovery in Tauopathies

Miyata, Y., Koren, J., Kiray, J., Dickey, C. A., & Gestwicki, J. E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.88 · Cited by 64 · see citing works

Organization and function of the FKBP52 and FKBP51 genes

Cioffi, D. L., Hubler, T. R., & Scammell, J. G. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.013 · Cited by 64 · see citing works

Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel

Shemesh, O. A., & Spira, M. E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.008 · Cited by 62 · see citing works

What is the pathological significance of tau oligomers?

Cowan, C. M., Quraishe, S., & Mudher, A. K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120135 · Cited by 62 · see citing works

Drosophila Models of Tauopathies: What Have We Learned?

Gistelinck, M., Lambert, J., Callaerts, P., Dermaut, B., & Dourlen, P. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/970980 · Cited by 58 · see citing works

Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects

Lathuilière, A., Valdés, P., Papin, S., Cacquevel, M., Maclachlan, C., Knott, G. W., Muhs, A., Paganetti, P., & Schneider, B. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-13786-2 · Cited by 53 · see citing works

Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: Focus on davunetide (NAP)

Magen, I., & Gozes, I. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.011 · Cited by 52 · see citing works

Original article Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis

Sarnat, H. B., Flores‐Sarnat, L., Crino, P. B., Hader, W. J., & Bello‐Espinosa, L. E. (2012) · Folia Neuropathologica · doi:10.5114/fn.2012.32363 · Cited by 52 · see citing works

Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation

Zhao, Z., Zhao, Y., Ning, Y.-L., Yang, N., Peng, Y., Li, P., Chen, X.-Y., Liu, D., Wang, H., Chen, X., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.98 · Cited by 52 · see citing works

Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation

Nijholt, D. A. T., Nölle, A., van Haastert, E. S., Edelijn, H., Toonen, R. F. G., Hoozemans, J. J. M., & Scheper, W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.008 · Cited by 48 · see citing works

Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62

Jung, H.-J., Kim, Y.-J., Eggert, S., Chung, K. C., Choi, K. S., & Park, S. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.07.013 · Cited by 47 · see citing works

Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons

Qin, Y., Zhang, Y., Tomic, I., Hao, W., Menger, M. D., Liu, C., Fassbender, K. C., & Liu, Y. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180426 · Cited by 47 · see citing works

Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies

Brunden, K. R., Ballatore, C., Lee, V. M. ‐., Smith, A. B., & Trojanowski, J. Q. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120010 · Cited by 46 · see citing works

Reducing the Levels of Akt Activation by PDK1 Knock-in Mutation Protects Neuronal Cultures against Synthetic Amyloid-Beta Peptides

Yang, S., Pascual-Guiral, S., Landete, R. P., Giménez‐Llort, L., Baltrons, M. A., Arancio, O., Palacio, J. R., Clos, M. V., Yuste, V. J., & Bayascas, J. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00435 · Cited by 44 · see citing works

Increased pro–nerve growth factor and decreased brain-derived neurotrophic factor in non–Alzheimer's disease tauopathies

Belrose, J. C., Masoudi, R., Michalski, B., & Fahnestock, M. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.029 · Cited by 43 · see citing works

Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers

Cowan, C. M., Quraishe, S., Hands, S. L., Sealey, M. A., Mahajan, S., Allan, D. W., & Mudher, A. K. (2015) · Scientific Reports · doi:10.1038/srep17191 · Cited by 39 · see citing works

Tanshinone IIA Ameliorates Spatial Learning and Memory Deficits by Inhibiting the Activity of ERK and GSK-3β

Li, L., Jadoon, S. S., Liu, S.-Z., Zhang, R., Li, F., Zhang, M.-Y., Ai-Hua, T., You, Q., & Wang, P. (2019) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719837373 · Cited by 38 · see citing works

Types of memory, dementia, Alzheimer’s disease, and their various pathological cascades as targets for potential pharmacological drugs

Akhtar, A., Singh, S., Kaushik, R., Awasthi, R., & Behl, T. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102289 · Cited by 37 · see citing works

Abnormal energy metabolism and tau phosphorylation in the brains of middle-aged mice in response to atmospheric PM2.5 exposure

Gao, R., Ku, T., Ji, X., Zhang, Y., Li, G., & Sang, N. (2017) · Journal of Environmental Sciences · doi:10.1016/j.jes.2017.06.037 · Cited by 37 · see citing works

Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer’s Disease

Yang, S., Du, Y., Zhao, X., Wu, C., & Yu, P. (2022) · Cells · doi:10.3390/cells11111735 · Cited by 36 · see citing works

Retinal Dysfunction in Alzheimer’s Disease and Implications for Biomarkers

Liao, C., Xu, J., Chen, Y., & Ip, N. Y. (2021) · Biomolecules · doi:10.3390/biom11081215 · Cited by 36 · see citing works

Post-translational modifications in neurodegeneration

Didonna, A., & Benetti, F. (2015) · AIMS Biophysics · doi:10.3934/biophy.2016.1.27 · Cited by 36 · see citing works

Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration

Chatterjee, S., Sealey, M. A., Ruiz, E., Pegasiou, C. M., Brookes, K. J., Green, S., Crisford, A., Duque-Vasquez, M., Luckett, E. S., Robertson, R., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0262792 · Cited by 35 · see citing works

Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension

Hu, J., Sha, W., Yuan, S., Wu, J., & Huang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915023 · Cited by 35 · see citing works

Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease

Gelman, S., Palma, J. D., Tombaugh, G. C., & Ghavami, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170457 · Cited by 35 · see citing works

Temporally distinct phosphorylations differentiate Tau-dependent learning deficits and premature mortality in Drosophila

Papanikolopoulou, K., & Skoulakis, E. M. C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu726 · Cited by 33 · see citing works

Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI

Bertrand, A., Khan, U., Hoang, D. M., Novikov, D. S., Krishnamurthy, P., Sait, H. B. R., Little, B. W., Sigurdsson, E. M., & Wadghiri, Y. Z. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.08.065 · Cited by 33 · see citing works

Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β

Povellato, G., Tuxworth, R. I., Hanger, D. P., & Tear, G. (2013) · Biology Open · doi:10.1242/bio.20136692 · Cited by 33 · see citing works

The Interplay Between Accumulation of Amyloid-Beta and Tau Proteins, PANoptosis, and Inflammation in Alzheimer’s Disease

Zhuang, X., Jie, L., Song, Y., Ban, R., Zhao, X., Xia, Z., Wang, Z., & Zhang, G. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08815-z · Cited by 32 · see citing works

Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity

Congdon, E. E., Pan, R., Jiang, Y., Sandusky‐Beltran, L. A., Dodge, A., Lin, Y., Liu, M., Kuo, M., Kong, X., & Sigurdsson, E. M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104249 · Cited by 32 · see citing works

The Fruit Fly, Drosophila melanogaster: Modeling of Human Diseases (Part II)

Allocca, M., Zola, S., & Bellosta, P. (2018) · InTech eBooks · doi:10.5772/intechopen.73199 · Cited by 30 · see citing works

Neuronal ageing is promoted by the decay of the microtubule cytoskeleton

Okenve-Ramos, P., Gosling, R., Chojnowska-Monga, M., Gupta, K., Shields, S., Alhadyian, H., Collie, C., Gregory, E., & Sánchez‐Soriano, N. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002504 · Cited by 29 · see citing works

Non-Rodent Genetic Animal Models for Studying Tauopathy: Review of Drosophila, Zebrafish, and C. elegans Models

Giong, H.-K., Subramanian, M., Yu, K., & Lee, J.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168465 · Cited by 29 · see citing works

Dynein Light Chain 1 (LC8) Association Enhances Microtubule Stability and Promotes Microtubule Bundling

Asthana, J., Kuchibhatla, A., Jana, S. C., Ray, K., & Panda, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394353 · Cited by 29 · see citing works

Activating autophagy to eliminate toxic protein aggregates with small molecules in neurodegenerative diseases

Fu, Y., Zhang, J., Qin, R., Ren, Y., Zhou, T., Han, B., & Liu, B. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100053 · Cited by 28 · see citing works

Protective effects of a small molecule inhibitor ligand against hyperphosphorylated tau-induced mitochondrial and synaptic toxicities in Alzheimer disease

Pradeepkiran, J. A., Munikumar, M., Reddy, A. P., & Reddy, P. H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab244 · Cited by 28 · see citing works

The Power and Richness of Modelling Tauopathies in Drosophila

Papanikolopoulou, K., & Skoulakis, E. M. C. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8193-1 · Cited by 28 · see citing works

Studying tauopathies in Drosophila: A fruitful model

Sun, M., & Chen, L. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.029 · Cited by 27 · see citing works

Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy

Ivashko‐Pachima, Y., & Gozes, I. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.07.008 · Cited by 25 · see citing works

Animal Models of Alzheimer’s Disease

Newman, M., Kretzschmar, D., Khan, I., Chen, M., Verdile, G., & Lardelli, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00040-1 · Cited by 24 · see citing works

How do neurons age? A focused review on the aging of the microtubular cytoskeleton

Richardson, B., Goedert, T., Quraishe, S., Deinhardt, K., & Mudher, A. K. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390974 · Cited by 24 · see citing works

Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes

Jung, H. J., Park, S. S., Mok, J. O., Lee, T. K., Park, C. S., & Park, S. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.01.012 · Cited by 24 · see citing works

Modelling Tauopathies in Drosophila : Insights from the Fruit Fly

Cowan, C. M., Sealey, M. A., Quraishe, S., Targett, M.-T., Marcellus, K. A., Allan, D. W., & Mudher, A. K. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/598157 · Cited by 23 · see citing works

An evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer’s disease

Sivanantharajah, L., Mudher, A. K., & Shepherd, D. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.01.001 · Cited by 23 · see citing works

Insights from Drosophila models of Alzheimer's disease

Cowan, C. M., Shepherd, D., & Mudher, A. K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380988 · Cited by 23 · see citing works

Curcumin as a Holistic Treatment for Tau Pathology

Sivanantharajah, L., & Mudher, A. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.903119 · Cited by 21 · see citing works

Astrocyte transport of glutamate and neuronal activity reciprocally modulate tau pathology in Drosophila

Kilian, J., Hsu, H.-W., Mata, K., Wolf, F. W., & Kitazawa, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.011 · Cited by 21 · see citing works

Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches

Atoki, A. V., Aja, P. M., Ondari, E. N., & Shinkafi, T. S. (2023) · International Journal of Food Properties · doi:10.1080/10942912.2023.2243050 · Cited by 19 · see citing works

Akt-activated GSK3β inhibitory peptide effectively blocks tau hyperphosphorylation

Lee, E., Lee, Y., Yang, S., Gong, E. J., Kim, J., Ha, N., Jo, D., Mattson, M. P., & Lee, J. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01513-1 · Cited by 19 · see citing works

Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice

Vargas-Caballero, M., Denk, F., Wobst, H. J., Arch, E., Pegasiou, C.-M., Oliver, P. L., Shipton, O. A., Paulsen, O., & Wade-Martins, R. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00201 · Cited by 18 · see citing works

Alzheimer’s disease: an axonal injury disease?

Liang, D., & Zhang, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1264448 · Cited by 18 · see citing works

Effect of taxoid and nontaxoid site microtubule‐stabilizing agents on axonal transport of mitochondria in untransfected and ECFP‐htau40‐transfected rat cortical neurons in culture

Das, V., Sim, D. A., & Miller, J. H. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23394 · Cited by 18 · see citing works

Disruption of Microtubule Integrity Initiates Mitosis during CNS Repair

Bossing, T., Barros, C. S., Fischer, B., Russell, S. R. H., & Shepherd, D. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.06.002 · Cited by 18 · see citing works

Suppression of tau‐induced phenotypes by vitamin E demonstrates the dissociation of oxidative stress and phosphorylation in mechanisms of tau toxicity

Cowan, C. M., Sealey, M. A., & Mudher, A. K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15253 · Cited by 17 · see citing works

GSK3β Impairs KIF1A Transport in a Cellular Model of Alzheimer’s Disease but Does Not Regulate Motor Motility at S402

Gan, K. J., Akram, A., Blasius, T. L., Ramser, E. M., Budaitis, B. G., Gabrych, D. R., Verhey, K. J., & Silverman, M. A. (2020) · eNeuro · doi:10.1523/eneuro.0176-20.2020 · Cited by 16 · see citing works

Intracellular tau fragment droplets serve as seeds for tau fibrils

Soeda, Y., Yoshimura, H., Bannai, H., Koike, R., Shiiba, I., & Takashima, A. (2024) · Structure · doi:10.1016/j.str.2024.06.018 · Cited by 15 · see citing works

Widespread hyperphosphorylated tau in the working memory circuit early after cortical impact injury of brain (Original study)

Zhao, Z., Ning, Y., Li, P., Yang, N., Peng, Y., Xiong, R., Zhao, Y., Liu, D., Zeng, X., Chen, J., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.02.002 · Cited by 15 · see citing works

Microtubule stabilising peptides rescue tau phenotypes in-vivo

Quraishe, S., Sealey, M. A., Cranfield, L., & Mudher, A. K. (2016) · Scientific Reports · doi:10.1038/srep38224 · Cited by 15 · see citing works

Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction

Pinzi, L., Conze, C., Bisi, N., Torre, G. D., Soliman, A., Monteiro-Abreu, N., Trushina, N. I., Krusenbaum, A., Dolouei, M. K., Hellwig, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45851-6 · Cited by 14 · see citing works

UsingDrosophilamodels of neurodegenerative diseases for drug discovery

Newman, T. A., Sinadinos, C., Johnston, A. H., Sealey, M. A., & Mudher, A. K. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.549124 · Cited by 14 · see citing works

The Drosophila model system to study tau action

Trotter, M., Stephens, T. D., McGrath, J. P., & Steinhilb, M. L. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.006 · Cited by 14 · see citing works

A Connected Network of Interacting Proteins Is Involved in Human-Tau Toxicity in Drosophila

Feuillette, S., Charbonnier, C., Frébourg, T., Campion, D., & Lecourtois, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00068 · Cited by 14 · see citing works

Therapeutic Targets in Alzheimer's Disease and Related Tauopathies

Corbo, C. P., & Alonso, A. D. C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00002-8 · Cited by 13 · see citing works

Tau Protein: Function and Pathology

Rosenmann, H., Blum, D. L., Kayed, R., & Ittner, L. M. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/707482 · Cited by 12 · see citing works

Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells

Clementi, L., Sabetta, S., Zelli, V., Compagnoni, C., Tessitore, A., Mattei, V., & Angelucci, A. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04721-2 · Cited by 11 · see citing works

F1‐01‐06: Soluble hyper‐phosphorylated tau causes microtubule breakdown and poisons normal tau in vivo

Mudher, A. K. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.175

O3‐05‐04: Soluble hyper‐phosphorylated tau disrupts the microtubule‐binding function of normal tau in vivo

Cowan, C. M., & Mudher, A. K. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.460 · Cited by 1 · see citing works

Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy

Cowan, C. M., Chee, F. C., Shepherd, D., & Mudher, A. K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380564 · Cited by 42 · see citing works

<i>Drosophila</i> models of human tauopathies indicate that Tau protein toxicity <i>in vivo</i> is mediated by soluble cytosolic phosphorylated forms of the protein

Feuillette, S., Miguel, L., Frébourg, T., Campion, D., & Lecourtois, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06663.x · Cited by 81 · see citing works

Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila

Talmat-Amar, Y., Arribat, Y., Redt‐Clouet, C., Feuillette, S., Bougé, A.-L., Lecourtois, M., & Parmentier, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr290 · Cited by 46 · see citing works